NeuroscienceeLifePeer-reviewed
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington’s disease
David Moreno‐Delgado, Mar Puigdellívol, Estefanía Moreno…·Peter James McCormick
This study identifies D1R-H3R heteromers as a therapeutic target for Huntington’s disease by showing their role in dopamine signaling and their modulation by H3R antagonists.